NMDA receptors are highly expressed in the CNS and are involved in excitatory synaptic transmission and synaptic plasticity as well as excitotoxicity. They have several binding sites for allosteric modulators, including neurosteroids, endogenous compounds synthesized by the nervous tissue and expected to act locally. Whole-cell patch-clamp recording from human embryonic kidney 293 cells expressing NR1-1a/NR2B receptors revealed that neurosteroid pregnenolone sulfate (PS) (300 microm), when applied to resting NMDA receptors, potentiates the amplitude of subsequent responses to 1 mm glutamate fivefold and slows their deactivation twofold. The same concentration of PS, when applied during NMDA receptor activation by 1 mm glutamate, has only a small effect. The association and dissociation rate constants of PS binding and unbinding from resting NMDA receptors are estimated to be 3.3 +/- 2.0 mm(-1)sec(-1) and 0.12 +/- 0.02 sec(-1), respectively, corresponding to an apparent affinity K(d) of 37 microm. The results of experiments indicate that the molecular mechanism of PS potentiation of NMDA receptor responses is attributable to an increase in the peak channel open probability (P(o)). Responses to glutamate recorded in the continuous presence of PS exhibit marked time-dependent decline. Our results indicate that the decline is induced by a change of the NMDA receptor affinity for PS after receptor activation. These results suggest that the PS is a modulator of NMDA receptor P(o), the effectiveness of which is lowered by glutamate binding. This modulation may have important consequences for the neuronal excitability.

Institute of Physiology Academy of Sciences of the Czech Republic 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Abdrachmanova G, Chodounska H, Vyklicky Jr L (2001) Effects of steroids on NMDA receptors and excitatory synaptic transmission in neonatal motoneurons in rat spinal cord slices. Eur J Neurosci 14: 495-502. PubMed

Akk G, Bracamontes J, Steinbach JH (2001) Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit. J Physiol (Lond) 532: 673-684. PubMed PMC

Arnostova LM, Pouzar V, Drasar P (1992) Synthesis of the sulfates derived from 5 alpha-cholestane-3 beta,6 alpha-diol. Steroids 57: 233-235. PubMed

Banke TG, Traynelis SF (2003) Activation of NR1/NR2B NMDA receptors. Nat Neurosci 6: 144-152. PubMed

Bowlby MR (1993) Pregnenolone sulfate potentiation of N-methyl-d-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 43: 813-819. PubMed

Ceccon M, Rumbaugh G, Vicini S (2001) Distinct effect of pregnenolone sulfate on NMDA receptor subtypes. Neuropharmacology 40: 491-500. PubMed

Chen N, Luo T, Raymond LA (1999) Subtype-dependence of NMDA receptor channel open probability. J Neurosci 19: 6844-6854. PubMed PMC

Clements JD, Westbrook GL (1991) Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor. Neuron 7: 605-613. PubMed

Corpechot C, Synguelakis M, Talha S, Axelson M, Sjovall J, Vihko R, Baulieu EE, Robel P (1983) Pregnenolone and its sulfate ester in the rat brain. Brain Res 270: 119-125. PubMed

Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51: 7-61. PubMed

Eisenman LN, He Y, Fields C, Zorumski CF, Mennerick S (2003) Activation dependent properties of pregnenolone sulfate inhibition of GABA(A) receptor-mediated current. J Physiol (Lond) 550: 679-691. PubMed PMC

Hollmann M, Boulter J, Maron C, Beasley L, Sullivan J, Pecht G, Heinemann S (1993) Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 10: 943-954. PubMed

Jahr CE (1992) High probability opening of NMDA receptor channels by l-glutamate. Science 255: 470-472. PubMed

Jang MK, Mierke DF, Russek SJ, Farb DH (2004) A steroid modulatory domain on NR2B controls N-methyl-d-aspartate receptor proton sensitivity. Proc Natl Acad Sci USA 101: 8198-8203. PubMed PMC

Kemp JA, McKernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci [Suppl] 5: 1039-1042. PubMed

Lester RA, Jahr CE (1992) NMDA channel behavior depends on agonist affinity. J Neurosci 12: 635-643. PubMed PMC

Majewska MD, Schwartz RD (1987) Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain? Brain Res 404: 355-360. PubMed

Majewska MD, Mienville JM, Vicini S (1988) Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 90: 279-284. PubMed

Malayev A, Gibbs TT, Farb DH (2002) Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol 135: 901-909. PubMed PMC

Mayer ML, Vyklicky Jr L, Clements J (1989a) Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338: 425-427. PubMed

Mayer ML, Vyklicky Jr L, Westbrook GL (1989b) Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones. J Physiol (Lond) 415: 329-350. PubMed PMC

Mendes P (1993) GEPASI: a software package for modelling the dynamics, steady states and control of biochemical and other systems. Comput Appl Biosci 9: 563-571. PubMed

Mendes P (1997) Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci 22: 361-363. PubMed

Mendes P, Kell D (1998) Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics 14: 869-883. PubMed

Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221. PubMed

Priestley T, Laughton P, Myers J, Le Bourdelles B, Kerby J, Whiting PJ (1995) Pharmacological properties of recombinant human N-methyl-d-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol Pharmacol 48: 841-848. PubMed

Sather W, Dieudonne S, MacDonald JF, Ascher P (1992) Activation and desensitization of N-methyl-d-aspartate receptors in nucleated outside-out patches from mouse neurones. J Physiol (Lond) 450: 643-672. PubMed PMC

Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A, Suter U, Carelli C, Baulieu EE, Akwa Y (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71: 3-29. PubMed

Shen W, Mennerick S, Covey DF, Zorumski CF (2000) Pregnenolone sulfate modulates inhibitory synaptic transmission by enhancing GABAA receptor desensitization. J Neurosci 20: 3571-3579. PubMed PMC

Turecek R, Vlcek K, Petrovic M, Horak M, Vlachova V, Vyklicky Jr L (2004) Intracellular spermine decreases open probability of N-methyl-d-aspartate receptor channels. Neuroscience 125: 879-887. PubMed

Vlachova V, Zemkova H, Vyklicky Jr L (1996) Copper modulation of NMDA responses in mouse and rat cultured hippocampal neurons. Eur J Neurosci 8: 2257-2264. PubMed

Vyklicky Jr L (1993) Calcium-mediated modulation of N-methyl-d-aspartate (NMDA) responses in cultured rat hippocampal neurones. J Physiol (Lond) 470: 575-600. PubMed PMC

Vyklicky Jr L, Benveniste M, Mayer ML (1990) Modulation of N-methyl-d-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones. J Physiol (Lond) 428: 313-331. PubMed PMC

Wu FS, Gibbs TT, Farb DH (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol Pharmacol 40: 333-336. PubMed

Wu FS, Chen SC, Tsai JJ (1997) Competitive inhibition of the glycine-induced current by pregnenolone sulfate in cultured chick spinal cord neurons. Brain Res 750: 318-320. PubMed

Yaghoubi N, Malayev A, Russek SJ, Gibbs TT, Farb DH (1998) Neurosteroid modulation of recombinant ionotropic glutamate receptors. Brain Res 803: 153-160. PubMed

Zorumski CF, Mennerick S, Isenberg KE, Covey DF (2000) Potential clinical uses of neuroactive steroids. Curr Opin Investig Drugs 1: 360-369. PubMed

Distinct Regulation of Early Trafficking of the NMDA Receptors by the Ligand-Binding Domains of the GluN1 and GluN2A Subunits

Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids

Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms

Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia

Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor

Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit

Cholesterol modulates open probability and desensitization of NMDA receptors

Key amino acid residues within the third membrane domains of NR1 and NR2 subunits contribute to the regulation of the surface delivery of N-methyl-D-aspartate receptors

20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor